1. Fluconazole for Preventing Radiation-Induced Oral Mucositis: A Randomized Controlled Trial.
- Author
-
Ueangphairot W, Muangwong P, Suwannaphong P, Youngchim S, Thammasit P, Kittidachanan K, and Chitapanarux I
- Abstract
Background: This study evaluated the efficacy of fluconazole prophylaxis in reducing radiation-induced oral mucositis (RIOM) and Candida carriage in head and neck cancer (HNC) patients undergoing concurrent chemoradiotherapy (CCRT)., Methods: A prospective, double-blinded, randomized controlled trial was conducted with 78 HNC patients receiving either fluconazole (100 mg daily) or placebo during CCRT. The primary outcome was the incidence of grade 2 or higher RIOM. Secondary outcomes included positive Candida cultures and colony-forming units (CFUs). Mixed-effects ordinal logistic regression and logistic regression were used for analysis., Results: Fluconazole significantly reduced the incidence of grade 2 or higher RIOM at week 7 (p = 0.039), positive Candida carriage at week 4 (p = 0.024) and week 7 (p = 0.029), and median CFUs at week 7 (p = 0.050)., Conclusions: Fluconazole significantly reduces RIOM severity and Candida colonization in HNC patients undergoing CCRT, suggesting its efficacy as a prophylactic treatment., (© 2024 The Author(s). Head & Neck published by Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF